These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18974104)
1. Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Briggs KJ; Eberhart CG; Watkins DN Cancer Res; 2008 Nov; 68(21):8654-6. PubMed ID: 18974104 [TBL] [Abstract][Full Text] [Related]
2. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN Genes Dev; 2008 Mar; 22(6):770-85. PubMed ID: 18347096 [TBL] [Abstract][Full Text] [Related]
3. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma. Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation? Jenal M; Britschgi C; Fey MF; Tschan MP Swiss Med Wkly; 2010; 140():w13106. PubMed ID: 21104471 [TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer. Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606 [TBL] [Abstract][Full Text] [Related]
7. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation. Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031 [TBL] [Abstract][Full Text] [Related]
8. The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). Dubuissez M; Faiderbe P; Pinte S; Dehennaut V; Rood BR; Leprince D Biochem Biophys Res Commun; 2013 Oct; 440(3):424-30. PubMed ID: 24076391 [TBL] [Abstract][Full Text] [Related]
9. Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response. Dehennaut V; Leprince D Bull Cancer; 2009 Nov; 96(11):E66-72. PubMed ID: 19822477 [TBL] [Abstract][Full Text] [Related]
10. [Chromosome arm 17p13.3: could HIC1 be the one ?]. Chopin V; Leprince D Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221 [TBL] [Abstract][Full Text] [Related]
11. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma. Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma. Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Rood BR; Zhang H; Weitman DM; Cogen PH Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291 [TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650 [TBL] [Abstract][Full Text] [Related]
15. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. Fiaschetti G; Abela L; Nonoguchi N; Dubuc AM; Remke M; Boro A; Grunder E; Siler U; Ohgaki H; Taylor MD; Baumgartner M; Shalaby T; Grotzer MA Br J Cancer; 2014 Feb; 110(3):636-47. PubMed ID: 24346283 [TBL] [Abstract][Full Text] [Related]
17. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification. Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915 [TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]